pinktest_usa_1752|NWPHF|Short Name|pe_ratio|shareholder_yield_ttm|enterprise_value|cash_on_hand|average_volume_30|one_year_return|price|ps_ratio|market_beta_12_month|total_deposits|dividend_yield|average_shares_outs_diluted|price_next_month|price_second_month
pinktest_usa_1752|NWPHF|Long Name|Newron Pharmaceuticals SpA PE Ratio|Newron Pharmaceuticals SpA Shareholder Yield (TTM)|Newron Pharmaceuticals SpA Enterprise Value (USD)|Newron Pharmaceuticals SpA Cash and Short Term Investments (Quarterly) (USD)|Newron Pharmaceuticals SpA 30-Day Average Daily Volume|Newron Pharmaceuticals SpA 1 Year Price Returns (Daily)|Newron Pharmaceuticals SpA Price (USD)|Newron Pharmaceuticals SpA PS Ratio|Newron Pharmaceuticals SpA Beta (1Y)|Newron Pharmaceuticals SpA Total Deposits (Quarterly) (USD)|Newron Pharmaceuticals SpA Dividend Yield|Newron Pharmaceuticals SpA Average Diluted Shares Outstanding (Quarterly)||
pinktest_usa_1752|NWPHF|Unit|figure_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_money_USD_price|figure_USD_metric|figure_USD_beta|mil_figure_money_USD_metric|percent_USD_metric|mil_figure_USD_metric||
pinktest_usa_1752|NWPHF|200912||||34.7404||||||||||
pinktest_usa_1752|NWPHF|201006||||16.0725||||||||||
pinktest_usa_1752|NWPHF|201012||||10.7554||||||||||
pinktest_usa_1752|NWPHF|201106||||14.7188||||||||||
pinktest_usa_1752|NWPHF|201112||||6.9519||||||||||
pinktest_usa_1752|NWPHF|201206||||19.2271||||||||||
pinktest_usa_1752|NWPHF|201212||||38.6739||||||||||
pinktest_usa_1752|NWPHF|201306||||28.3672||||||||||
pinktest_usa_1752|NWPHF|201312||||25.4439||||||||||
pinktest_usa_1752|NWPHF|||||42.8254|||||||||26.125|26.125
pinktest_usa_1752|NWPHF|201409|||272.737||||24.0625|75.6603|||0||24.0625|24.0625
pinktest_usa_1752|NWPHF|201412||||31.2541||||||||||
pinktest_usa_1752|NWPHF|201506||||49.3504||||||||||
pinktest_usa_1752|NWPHF||||||||||-0.2329||||28.9|28.9
pinktest_usa_1752|NWPHF|201512||||44.7499|||||1.5845|||||
pinktest_usa_1752|NWPHF|201603|||238.295|||-8.7461|19.85|103.7378|0.3268||0|||
pinktest_usa_1752|NWPHF|||||38.7973|||||0.3326||||20.75|20.75
pinktest_usa_1752|NWPHF|201609|||||||||0.4054|||||
pinktest_usa_1752|NWPHF|||||49.1241|||||-1.9112||||20.37|20.37
pinktest_usa_1752|NWPHF|201703|||307.735|||13.8539|22.6|61.8435|-0.5575||0||22.18|22.18
pinktest_usa_1752|NWPHF|||||51.5551|||||-0.5868||||19|19
pinktest_usa_1752|NWPHF|201709|||215.76|||-18.6024|16.89|19.8169|-0.081||0||14.6|14.6
pinktest_usa_1752|NWPHF|201712|||153.5532|72.0792||-44.5783|11.5|13.4928|-1.7817||0||12.41|12.41
pinktest_usa_1752|NWPHF||||||||||1.4013||||8.92|8.92
pinktest_usa_1752|NWPHF|||||58.5459|||||1.5482||||10.9508|10.9508
pinktest_usa_1752|NWPHF|201809|||137.6644||1114.1|-40.0545|11|42.8669|1.9363||0|||
pinktest_usa_1752|NWPHF|201812||0.0045|146.1349|50.1634|1067.3667|-4.3478|11|41.7727|0.8535||0||11|11
pinktest_usa_1752|NWPHF|201903|||110.4443||17.8|-15.9664|9|34.1777|0.1328||0||9|9
pinktest_usa_1752|NWPHF|201906||-2.183|114.9056|33.4369|0|0.0611|9.25|35.1271|0.0996||0||9.25|9.25
pinktest_usa_1752|NWPHF|201909|||142.2608||0|-15.9091|9.25|34.3267|-0.0516||0||9.25|9.25
pinktest_usa_1752|NWPHF|201912|||111.0315|43.8692|11.6667|-31.8182|7.5|27.8325|-0.0748||0||7.5|7.5
pinktest_usa_1752|NWPHF|202003|||108.7323||0|-16.6667|7.5|17.0946|-0.1798||0||7.5|7.5
pinktest_usa_1752|NWPHF|202006||-28.8578|15.809|44.2726|309.9|-80.4324|1.81|3.995|-0.171||0||1.81|1.81
pinktest_usa_1752|NWPHF|202009|||29.0145||20|-72.4324|2.55|5.6283|0.4102||0||2|2